139 related articles for article (PubMed ID: 28202320)
1. The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment.
Kingsberg SA; Krychman M; Graham S; Bernick B; Mirkin S
J Sex Med; 2017 Mar; 14(3):413-424. PubMed ID: 28202320
[TBL] [Abstract][Full Text] [Related]
2. Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India.
Ulhe SC; Acharya N; Vats A; Singh A
Cureus; 2024 Feb; 16(2):e54802. PubMed ID: 38529421
[TBL] [Abstract][Full Text] [Related]
3. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy.
Kingsberg S; Kellogg S; Krychman M
Int J Womens Health; 2010 Aug; 1():105-11. PubMed ID: 21072280
[TBL] [Abstract][Full Text] [Related]
4. Ospemifene for vulvar and vaginal atrophy: an overview.
Palacios S
Drugs Context; 2020; 9():. PubMed ID: 32670378
[TBL] [Abstract][Full Text] [Related]
5. Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials.
Gass M; Larson J; Cochrane B; Manson JE; Lane D; Barnabei V; Ockene J; Stefanick ML; Mouton C
Menopause; 2018 Mar; 25(3):252-264. PubMed ID: 29112594
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Symptoms and Prevention of Cancer in Menopause: The Value of Vulvar Exam.
Palumbo AR; Fasolino C; Santoro G; Gargano V; Rinaldi M; Arduino B; Belli M; Guida M
Transl Med UniSa; 2016 Nov; 15():74-79. PubMed ID: 27896230
[TBL] [Abstract][Full Text] [Related]
7. Reviewing the options for local estrogen treatment of vaginal atrophy.
Lindahl SH
Int J Womens Health; 2014; 6():307-12. PubMed ID: 24648775
[TBL] [Abstract][Full Text] [Related]
8. Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause.
Pięta W; Smolarczyk R
Prz Menopauzalny; 2020 Dec; 19(4):195-199. PubMed ID: 33488333
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of vulvovaginal symptoms in Japanese women of reproductive and perimenopausal ages: A cross-sectional study across generations.
Kawai T; Harada M; Yamada K; Ugomori R; Osuga Y
J Obstet Gynaecol Res; 2024 May; 50(5):914-919. PubMed ID: 38438124
[TBL] [Abstract][Full Text] [Related]
10. Systemic effects of vaginally administered estrogen therapy: a review.
Krause M; Wheeler TL; Richter HE; Snyder TE
Female Pelvic Med Reconstr Surg; 2010 May; 16(3):188-95. PubMed ID: 22453284
[TBL] [Abstract][Full Text] [Related]
11. Women's information needs about menopause: a cross-sectional survey in Norwegian general practice.
Natvik M; Gjelsvik B; Vangen S; Skjeie H; Brekke M
BJGP Open; 2024 Apr; 8(1):. PubMed ID: 37669803
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin Nephrotoxicity Might Have a Sex Difference. An analysis Based on Women's Sex Hormone Changes.
Chen WY; Hsiao CH; Chen YC; Ho CH; Wang JJ; Hsing CH; Wang HY; Kan WC; Wu CC
J Cancer; 2017; 8(19):3939-3944. PubMed ID: 29187868
[No Abstract] [Full Text] [Related]
13. Overweight and obese women's symptoms, knowledge, and preferences regarding endometrial biopsy for endometrial cancer detection: A threshold technique survey.
Beavis AL; Hirani Z; Rushton T; Rush MC; Fader AN; Yenokyan G; Rositch AF
Gynecol Oncol Rep; 2024 Apr; 52():101361. PubMed ID: 38469133
[TBL] [Abstract][Full Text] [Related]
14.
J Womens Health (Larchmt); 2024 Feb; 33(2):262-268. PubMed ID: 38363964
[No Abstract] [Full Text] [Related]
15. Current treatment options for postmenopausal vaginal atrophy.
Naumova I; Castelo-Branco C
Int J Womens Health; 2018; 10():387-395. PubMed ID: 30104904
[TBL] [Abstract][Full Text] [Related]
16. The 2017 hormone therapy position statement of The North American Menopause Society.
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
[TBL] [Abstract][Full Text] [Related]
17. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
[TBL] [Abstract][Full Text] [Related]
18. Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women.
Constantine GD; Bouchard C; Pickar JH; Archer DF; Graham S; Bernick B; Mirkin S
J Womens Health (Larchmt); 2017 Jun; 26(6):616-623. PubMed ID: 28355090
[TBL] [Abstract][Full Text] [Related]
19. Sexual Health in Menopause.
Scavello I; Maseroli E; Di Stasi V; Vignozzi L
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31480774
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
